Stock listing
NYSE American:MAIA MAIA Biotechnology, Inc. Stock
Home listing (NYSE American) of MAIA Biotechnology, Inc.
Follow MAIA Biotechnology, Inc. into a list and get an email when it puts out news.
Share price · AMEX:MAIA
$1.10 USD -0.08 (-6.8%)
Close on Oct 30, 2026
- Day range
- $1.10 – $1.17 USDOct 30, 2026
- Volume
- 313,639 sharesOct 30, 2026
- Market cap
- $67.92M USDAt the close on Oct 30, 2026 · price × 61.74M shares outstanding
- 52-week range
- $0.87 – $3.19 USDLowest and highest trades, Oct 31, 2025 – Oct 30, 2026
- Traded on an average day
- $583,970 USDMedian day 353,545 shares · last 3 months, Jul 30, 2026 – Oct 30, 2026

Prices by listing
| Listing | Last | Change | Volume | Open | High | Low | Previous close | Price from |
|---|---|---|---|---|---|---|---|---|
| NYSE American:MAIA · Home | $1.10 USD | -0.08 (-6.8%) | 313,639 | $1.16 | $1.17 | $1.10 | $1.18 | Close on Oct 30, 2026 |
Daily closes
Last 3 months, Jul 30, 2026 – Oct 30, 2026 · AMEX:MAIA · USD, adjusted for splits
| Day | Close | Change | % | Open | High | Low | Volume |
|---|---|---|---|---|---|---|---|
| $1.10 | -0.08 | -6.8% | $1.16 | $1.17 | $1.10 | 313,639 | |
| $1.18 | +0.02 | +1.7% | $1.17 | $1.22 | $1.16 | 172,010 | |
| $1.16 | -0.01 | -0.9% | $1.16 | $1.18 | $1.11 | 236,228 | |
| $1.17 | +0.06 | +5.4% | $1.14 | $1.185 | $1.10 | 301,097 | |
| $1.11 | -0.04 | -3.5% | $1.15 | $1.15 | $1.10 | 279,975 | |
| $1.15 | +0.02 | +1.8% | $1.13 | $1.15 | $1.12 | 141,079 | |
| $1.13 | -0.01 | -0.9% | $1.14 | $1.15 | $1.12 | 92,282 | |
| $1.14 | +0.02 | +1.8% | $1.13 | $1.15 | $1.06 | 107,870 | |
| $1.12 | +0.05 | +4.7% | $1.08 | $1.13 | $1.07 | 184,536 | |
| $1.07 | -0.03 | -2.7% | $1.09 | $1.10 | $1.06 | 799,140 | |
| $1.10 | -0.02 | -1.8% | $1.13 | $1.15 | $1.08 | 363,522 | |
| $1.12 | 0.00 | 0.0% | $1.10 | $1.15 | $1.10 | 296,930 | |
| $1.12 | -0.04 | -3.4% | $1.15 | $1.16 | $1.10 | 628,703 | |
| $1.16 | -0.02 | -1.7% | $1.18 | $1.18 | $1.15 | 277,469 | |
| $1.18 | -0.04 | -3.3% | $1.22 | $1.22 | $1.16 | 229,957 | |
| $1.22 | +0.07 | +6.1% | $1.16 | $1.24 | $1.16 | 375,298 | |
| $1.15 | -0.03 | -2.5% | $1.15 | $1.16 | $1.13 | 677,144 | |
| $1.18 | -0.01 | -0.8% | $1.17 | $1.22 | $1.16 | 359,676 | |
| $1.19 | +0.01 | +0.8% | $1.20 | $1.21 | $1.175 | 227,156 | |
| $1.18 | -0.01 | -0.8% | $1.17 | $1.21 | $1.17 | 531,014 | |
| $1.19 | +0.02 | +1.7% | $1.19 | $1.21 | $1.17 | 405,026 | |
| $1.17 | -0.01 | -0.8% | $1.18 | $1.22 | $1.15 | 781,506 | |
| $1.18 | +0.03 | +2.6% | $1.17 | $1.19 | $1.15 | 691,458 | |
| $1.15 | -0.03 | -2.5% | $1.20 | $1.215 | $1.15 | 677,550 | |
| $1.18 | -0.02 | -1.7% | $1.23 | $1.265 | $1.18 | 1,011,106 | |
| $1.20 | -0.05 | -4.0% | $1.27 | $1.33 | $1.20 | 920,683 | |
| $1.25 | -0.07 | -5.3% | $1.31 | $1.33 | $1.25 | 594,997 | |
| $1.32 | -0.05 | -3.6% | $1.35 | $1.36 | $1.30 | 627,034 | |
| $1.37 | +0.04 | +3.0% | $1.33 | $1.37 | $1.31 | 940,373 | |
| $1.33 | +0.02 | +1.5% | $1.35 | $1.38 | $1.30 | 1,142,693 | |
| $1.31 | -0.09 | -6.4% | $1.37 | $1.398 | $1.31 | 468,257 | |
| $1.40 | 0.00 | 0.0% | $1.44 | $1.45 | $1.36 | 649,196 | |
| $1.40 | +0.06 | +4.5% | $1.35 | $1.42 | $1.34 | 907,382 | |
| $1.34 | -0.05 | -3.6% | $1.42 | $1.46 | $1.33 | 1,186,176 | |
| $1.39 | +0.09 | +6.9% | $1.30 | $1.40 | $1.30 | 800,151 | |
| $1.30 | -0.01 | -0.8% | $1.32 | $1.32 | $1.27 | 682,402 | |
| $1.31 | -0.02 | -1.5% | $1.36 | $1.36 | $1.30 | 333,193 | |
| $1.33 | +0.02 | +1.5% | $1.33 | $1.38 | $1.325 | 553,903 | |
| $1.31 | -0.01 | -0.8% | $1.32 | $1.348 | $1.30 | 226,662 | |
| $1.32 | -0.01 | -0.8% | $1.35 | $1.35 | $1.30 | 243,248 | |
| $1.33 | -0.04 | -2.9% | $1.38 | $1.40 | $1.31 | 470,785 | |
| $1.37 | +0.07 | +5.4% | $1.40 | $1.46 | $1.355 | 865,839 | |
| $1.30 | -0.01 | -0.8% | $1.30 | $1.32 | $1.28 | 331,349 | |
| $1.31 | -0.02 | -1.5% | $1.33 | $1.33 | $1.295 | 258,682 | |
| $1.33 | -0.05 | -3.6% | $1.38 | $1.38 | $1.32 | 361,316 | |
| $1.38 | -0.01 | -0.7% | $1.40 | $1.40 | $1.37 | 263,099 | |
| $1.39 | -0.02 | -1.4% | $1.41 | $1.471 | $1.385 | 558,009 | |
| $1.41 | +0.06 | +4.4% | $1.40 | $1.46 | $1.36 | 943,165 | |
| $1.35 | -0.04 | -2.9% | $1.40 | $1.40 | $1.325 | 227,998 | |
| $1.39 | +0.01 | +0.7% | $1.38 | $1.405 | $1.35 | 379,842 | |
| $1.38 | -0.01 | -0.7% | $1.37 | $1.40 | $1.36 | 223,259 | |
| $1.39 | +0.02 | +1.5% | $1.40 | $1.42 | $1.38 | 337,165 | |
| $1.37 | -0.02 | -1.4% | $1.39 | $1.40 | $1.36 | 235,781 | |
| $1.39 | -0.01 | -0.7% | $1.40 | $1.40 | $1.35 | 266,978 | |
| $1.40 | +0.06 | +4.5% | $1.34 | $1.40 | $1.34 | 569,026 | |
| $1.34 | -0.04 | -2.9% | $1.36 | $1.385 | $1.34 | 179,087 | |
| $1.38 | 0.00 | 0.0% | $1.35 | $1.39 | $1.335 | 179,640 | |
| $1.38 | -0.03 | -2.1% | $1.40 | $1.41 | $1.36 | 276,270 | |
| $1.41 | -0.01 | -0.7% | $1.38 | $1.41 | $1.38 | 202,835 | |
| $1.42 | 0.00 | 0.0% | $1.42 | $1.44 | $1.39 | 333,250 | |
| $1.42 | +0.02 | +1.4% | $1.47 | $1.47 | $1.38 | 347,413 | |
| $1.40 | +0.04 | +2.9% | $1.38 | $1.41 | $1.36 | 276,099 | |
| $1.36 | +0.04 | +3.0% | $1.32 | $1.38 | $1.31 | 384,213 | |
| $1.32 | +0.07 | +5.6% | $1.25 | $1.32 | $1.23 | 650,171 | |
| $1.25 | 0.00 | 0.0% | $1.25 | $1.27 | $1.21 | 231,913 | |
| $1.25 | +0.05 | +4.2% | $1.22 | $1.27 | $1.19 | 290,595 |
- Ticker
- NYSE American:MAIA
- Asset type
- Stock
- Sector
- Health care
- Industry
- Biotechnology
- Exchange
- NYSE American
- Currency
- USD
What changed lately
Latest news release · Sep 16, 2026
MAIA Biotechnology Doses First U.S. Patient in Ongoing Phase 2 Non-Small Cell Lung Cancer Clinical Trial
Latest deck · Oct 6, 2026
Investor Presentation (October 2026)
Investor deck · 28 slides
Latest news
MAIA Biotechnology Doses First U.S. Patient in Ongoing Phase 2 Non-Small Cell Lung Cancer Clinical Trial
Sep 16, 2026
Closed $1.40 (+4.5%) on Sep 16, 2026
MAIA Biotechnology Announces Open Market Purchases of Company Stock by Long-Standing Board Member and CEO
Sep 15, 2026
Closed $1.34 (-3.6%) on Sep 15, 2026
MAIA Biotechnology Delivers Oral and Poster Presentations Showcasing Next-Generation Telomere-Targeting Cancer Therapies at IRT 2026
Sep 10, 2026
Closed $1.31 (-1.5%) on Sep 10, 2026
MAIA Biotechnology Reports Strong Initial Efficacy Data in Third-Line Non-Small Cell Lung Cancer from Phase 2 THIO-101 Part C Expansion Trial
Jul 8, 2026
Closed $1.47 (0.0%) on Jul 8, 2026
MAIA Biotechnology Completes International Enrollment in Part C of Phase 2 THIO-101 Expansion Trial in Third-Line Non-Small Cell Lung Cancer
Jun 25, 2026
Closed $1.35 (-2.9%) on Jun 25, 2026
MAIA Biotechnology Opens Enrollment for Phase 2 Expansion Trial of Novel Telomere-Targeting Agent at Winship Cancer Institute of Emory University
Jun 18, 2026
Closed $1.40 (+6.1%) on Jun 18, 2026
MAIA Biotechnology Reports Strong Enrollment and Dosing Momentum in Pivotal Phase 3 Non-Small Cell Lung Cancer Trial
Jun 4, 2026
Closed $1.50 (+4.9%) on Jun 4, 2026
MAIA Biotechnology Receives FDA Clearance to Open U.S. Enrollment in Ongoing Phase 2 THIO-101 Trial Expansion
Jun 3, 2026
Closed $1.43 (+5.9%) on Jun 3, 2026
MAIA Biotechnology Announces Open Market Purchases by CEO and Director
Jun 2, 2026
Closed $1.35 (+3.8%) on Jun 2, 2026
Decks
Investor Presentation (October 2026)
Investor deck · 28 slides · Oct 6, 2026
Investor Presentation (January 2026)
Investor deck · 25 slides · Jan 13, 2026
Investor Presentation (2026)
Investor deck · 28 slides · 2026
Investor Presentation (September 2025)
Investor deck · 29 slides · Sep 12, 2025
MAIA Biotechnology, Inc. on 6ix
- Sector
- Health care
- Industry
- Biotechnology
- News releases
- 24 in the last 12 months · 47 in all · newest Sep 16, 2026 · oldest 2025
- Decks
- 23 decks · latest Oct 6, 2026
Where MAIA Biotechnology, Inc. is listed
| Listing | Exchange | Country | Currency |
|---|---|---|---|
| NYSE American:MAIA · Home listing · This page | NYSE American | United States | USD |
| BOATS:MAIA | BOATS | United States | USD |
Log in to ask 6ix AI your own questions about MAIA Biotechnology, Inc.